Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients

被引:0
作者
K. Rossing
P. K. Christensen
P. Hovind
H.-H. Parving
机构
[1] Steno Diabetes Center,Faculty of Health Science
[2] Aarhus University,undefined
来源
Diabetologia | 2005年 / 48卷
关键词
Albuminuria; Antihypertensive treatment; Blood pressure; Diabetic nephropathy; End-stage renal disease; Mortality; Nephrotic-range albuminuria; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2241 / 2247
页数:6
相关论文
共 78 条
[1]  
Kussman MJ(1976)The clinical course of diabetic nephropathy JAMA 236 1861-1863
[2]  
Goldstein H-H(1972)The natural history of diabetic renal disease. A follow-up study of series of renal biopsies Q J Med 41 437-456
[3]  
Gleason RE(1994)Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment Diabetologia 37 511-516
[4]  
Watkins PJ(2004)Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL Kidney Int 65 2309-2320
[5]  
Blainey JD(2004)Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy Circulation 110 921-927
[6]  
Brewer DB(1976)Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment Scand J Clin Lab Invest 36 383-388
[7]  
Rossing P(1981)A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy Diabetologia 20 457-461
[8]  
Hommel E(2001)Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861-869
[9]  
Smidt UM(2001)Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851-860
[10]  
Parving H-H(1994)Remission of nephrotic-range proteinuria in type I diabetes Kidney Int 46 1688-1693